12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Recent advances in chemoprevention of cancer.

      Science (New York, N.Y.)
      Animals, Anticarcinogenic Agents, therapeutic use, Chemoprevention, Clinical Trials as Topic, Drug Therapy, Combination, Humans, Neoplasm Recurrence, Local, prevention & control, Neoplasms, etiology, pathology, Neoplasms, Second Primary, Precancerous Conditions, drug therapy, Risk Factors, Tumor Markers, Biological, analysis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chemoprevention is the use of pharmacologic or natural agents that inhibit the development of invasive cancer either by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. Recent advances in our understanding of the mechanisms of carcinogenesis have led to the synthesis of new drugs that can inhibit tumor development in experimental animals by selective action on specific molecular targets, such as the estrogen, androgen, and retinoid receptors or inducible cyclooxygenase. Several of these agents (including tamoxifen, 13-cis-retinoic acid, retinyl palmitate, and an acyclic retinoid) are clinically effective in preventing the development of cancer, particularly in patients who are at high risk for developing second primary tumors after surgical removal of the initial tumor.

          Related collections

          Author and article information

          Comments

          Comment on this article